Rosette forming glioneuronal tumor in association with Noonan syndrome: Pathobiological implications

35Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Noonan syndrome, a distinctive syndrome characterized by dysmorphism, cardiac abnormalities and developmental delay, has been associated with a number of malignancies, however, only a few cases of primary glial or glioneuronal neoplasms have been reported. We report here the case of an 18-year-old with Noonan syndrome who developed a rosette forming glioneuronal tumor of the posterior fossa. The tumor demonstrated strong pERK immunoreactivity, suggesting MAPK/ERK pathway activation. Molecular testing did not reveal BRAF rearrangements (fusion transcripts) by PCR or a BRAF V600E mutation by sequencing. We review the literature regarding the molecular pathogenesis of Noonan syndrome and primary brain tumors, and consider the intriguing link between their common molecular pathways. © 2011 Dustri-Verlag Dr. K. Feistle.

Cite

CITATION STYLE

APA

Karafin, M., Jallo, G. I., Ayars, M., Eberhart, C. G., & Rodriguez, F. J. (2011). Rosette forming glioneuronal tumor in association with Noonan syndrome: Pathobiological implications. Clinical Neuropathology, 30(6), 297–300. https://doi.org/10.5414/NP300374

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free